2 completed. 2 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 2 | Completed 2 |
Follow Si-Yu Wang: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Neoadjuvant Pemetrexed, Carboplatin and Bevacizumab in Unresectable, Locally Advanced Lung Adenocarcinoma Neoadjuvant Bevacizumab - Lung Cancer | Phase 2 | Completed | Si-Yu Wang | 42 | 2012-04-01 | 2015-01-22 |
| Erlotinib Versus Pemetrexed as Second-Line Therapy in Treating Patients With Advanced Lung Adenocarcinoma Erlotinib, Pemetrexed - Lung Cancer | Phase 2 | Completed | Si-Yu Wang | 123 | 2008-12-01 | 2014-09-15 |
Lung Neoplasms (2) · Adenocarcinoma (1) · Adenocarcinoma of Lung (1) · Carcinoma, Non-Small-Cell Lung (1) · Neoplasms (1)
Pemetrexed (2) · Bevacizumab (1) · Erlotinib Hydrochloride (1)
China (2)